Board Member
Kymera Therapeutics, Inc. (KYMR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2019-01-01–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CFO, Board Member
2019-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Kymera Therapeutics, Inc. (KYMR) | CFA, MBA Chief Financial Officer | $500,000 | $2,903,236 |
| 2024 | Kymera Therapeutics, Inc. (KYMR) | CFA, MBA Chief Financial Officer | $481,000 | $7,140,817 |
| 2023 | Kymera Therapeutics, Inc. (KYMR) | CFA, MBA Chief Financial Officer | $470,000 | $4,155,156 |
| 2022 | Kymera Therapeutics, Inc. (KYMR) | CFA, MBA Chief Financial Officer | $441,738 | $2,893,316 |
| 2021 | Kymera Therapeutics, Inc. (KYMR) | CFA, MBA Chief Financial Officer | $415,539 | $4,599,562 |
| 2020 | Kymera Therapeutics, Inc. (KYMR) | CFA, MBA Chief Financial Officer | $369,020 | $1,262,902 |
Earnings-call appearances and filed executive appointments or departures, newest first.
